Advanced search
Publication Cover
Renal Failure Volume 43, 2021 - Issue 1
Submit an article Journal homepage
1,291
Views
3
CrossRef citations to date
0
Altmetric
Clinical Study

Normotensive and hypertensive Immunoglobulin a nephropathy with ischemic renal injury: clinicopathological characteristics and prognosis

Yongli Wanga Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information
,
Xutong Wanga Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information
,
Dan Yua Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information
,
Minhua Xiea Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information
,
Jingjing Rena Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information
,
Yuze Zhua Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information
,
Haonan Guoa Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information
,
Songxia Quanb Department of Renal Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information
&
Junjun Zhanga Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1454-1462 | Received 08 Jun 2021, Accepted 12 Oct 2021, Published online: 27 Oct 2021

References

  • Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004;66(3):920–923.
  • , Roberts ISD, Cook HT, Troyanov S, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76(5):546–556.
  • Le W, Liang S, Hu Y, et al. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant. 2012;27(4):1479–1485.
  • Zou WZ. Renal biopsy pathology [M]. 4th ed. Beijing: Peking University Med Publisher; 2016.
  • Øvrehus MA, Oldereid TS, Dadfar A, et al. Clinical phenotypes and long-term prognosis in white patients with biopsy-verified hypertensive nephrosclerosis. Kidney Int Rep. 2020;5(3):339–347.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate [published correction appears in Ann Intern Med. 2011;155(6):408]. Ann Intern Med. 2009;150(9):604–612.
  • KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl. 2011;2:142.
  • Trimarchi H, Barratt J, Cattran DC, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017;91(5):1014–1021.
  • Revision Committee of Chinese Guideline for Hypertension prevention and Treatment, Chinese Society of Cardiology of Hypertension Alliance (China), Hypertension Professional Committee of Chinese Medical Doctor Association, etc. Chinese Guidelines for hypertension prevention and Treatment (2018 Revision). Chin J Cardio Med. 2019;24:24–56.
  • Chen XJ, Yu XJ, Wang SX, et al. Clinical and pathological characteristics of ischemic renal injury. Chin J Nephrol. 2020;36:6–12.
  • Rodrigues JC, Haas M, Reich HN. IgA nephropathy. Clin J Am Soc Nephrol. 2017;12(4):677–686.
  • Maixnerova D, Reily C, Bian Q, et al. Markers for the progression of IgA nephropathy. J Nephrol. 2016;29(4):535–541.
  • Ray SC, Mason J, O'Connor PM. Ischemic renal injury: can renal anatomy and associated vascular congestion explain why the medulla and not the cortex is where the trouble starts? Semin Nephrol. 2019;39(6):520–529.
  • Gigante A, Giannakakis K, Di Mario F, et al. BMI, nephroangiosclerosis and glomerulonephritis: is there any meeting point? Nephrology. 2018;23(11):991–996.
  • Momoki K, Kataoka H, Moriyama T, et al. Hyperuricemia as a predictive marker for progression of nephrosclerosis: clinical assessment of prognostic factors in Biopsy-Proven arterial/arteriolar nephrosclerosis. J Atheroscler Thromb. 2017;24(6):630–642.
  • Chua JS, Zandbergen M, Wolterbeek R, et al. Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis. Mod Pathol. 2019;32(8):1147–1157.
  • Liang S, Le W, Liang D, et al. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study. BMC Nephrol. 2016;17:42.
  • Chen T, Li X, Li Y, et al. Prediction and risk stratification of kidney outcomes in IgA nephropathy. Am J Kidney Dis. 2019;74(3):300–309.
  • Kang SH, Choi SR, Park HS, et al. The oxford classification as a predictor of prognosis in patients with IgA nephropathy. Nephrol Dial Transplant. 2012;27(1):252–258.
  • Wu J, Chen X, Xie Y, et al. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Nephrol Dial Transplant. 2005;20(4):719–727.
  • Chen TX, Chen B, Chen XX, et al. Comparative analysis of clinicopathological characteristics and outcomes in malignant hypertension patients with and without primary glomerular diseases. Chin J Nephrol. 2019;35:906–913.
  • Sulikowska B, Rutkowski B, Marszałek A, et al. The role of interstitial changes in the progression of chronic kidney disease. Postepy Hig Med Dosw. 2015;69:830–837.
  • Zheng Y, Wang Y, Liu S, et al. Potential blood pressure goals in IgA nephropathy: prevalence, awareness, and treatment rates in chronic kidney disease among patients with hypertension in China (PATRIOTIC) study. Kidney Blood Press Res. 2018;43(6):1786–1795.
  • Berthoux F, Mohey H, Laurent B, et al. Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol. 2011;22(4):752–761.
  • Goto M, Wakai K, Kawamura T, et al. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant. 2009;24(10):3068–3074.
  • Cheung AK, Rahman M, Reboussin DM, et al. Effects of intensive BP control in CKD. J Am Soc Nephrol. 2017;28(9):2812–2823.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.